CGE2025v13n2

1 Introduction 31
2 Review of Histone Modification 32
2.1 Structure and function of histones and chromat 32
Histones are the core proteins that compress DNA a 32
Chromatin is not fixed but a flexible structure th 32
2.2 Histone modification types 32
Histone modification is a chemical alteration (PTM 32
Acetylation mainly occurs on lysine and is usually 32
2.3 The general role of histone modification in ge 32
Histone modification plays a core role in controll 32
In cancer, the imbalance of histone modification i 33
3 The role of Histone Methylation in Prostate Canc 33
3.1 Histone methylation mechanisms: H3K4, H3K9, H3 33
Histone methylation is a key epigenetic change tha 33
H3K27 methylation catalyzed by the multi-comb inhi 33
3.2 Dysmethylation in prostate cancer: its role in 34
The imbalance of histone methylation is an importa 34
The mutual influence among different histone marke 34
3.3 Therapeutic significance: targeting methyltran 34
Targeting histone methyltransferases and demethyla 34
Targeting NSD2 and other H3K36 methyltransferases 34
4 The Role of Histone Acetylation in Prostate Canc 34
4.1 The role of acetylation in chromatin structure 34
Histone acetylation is an important chemical modif 34
Li et al. (2020) found that acetylation and deacet 34
4.2 Histone acetyltransferases and histone deacety 34
During the occurrence and development of prostate 34
4.3 Therapeutic potential of HDAC inhibitors 35
HDAC inhibitors (HDACi) have brought new hope for 35
5 Crosstalk of Five Histone Modifications in Prost 36
5.1 Synergistic effects among different histone mo 36
Histone modifications do not function alone; there 36
There is a mutual inhibitory relationship between 36
5.2 Chromatin remodeling and transcriptional regul 36
The changes in chromatin structure are an importan 36
When histone variants like H3.3 bind to chromatin, 36
5.3 Role in the invasion and progression of prosta 36
The interaction among histone modifications is not 36
6 Histone Modification and Drug Resistance in Pros 37
6.1 The role of histone modification in the occurr 37
Histone modification has a significant impact on a 37
Imamura et al. (2023) found that prostate cancer c 37
6.2 Epigenetic reprogramming leading to drug resis 38
Epigenetic reprogramming, including histone modifi 38
6.3 Clinical significance of histone modification 38
Histone modification has a high clinical value in 38
7 Emerging Treatment Methods for Histone Modificat 38
7.1 Development of epigenetic drugs: HDAC and meth 38
The development of epigenetic drugs is very promis 38
7.2 Combination therapy for histone modification a 38
Combining epigenetic drugs with traditional cancer 38
7.3 Clinical outcomes and challenges of prostate c 38
8 Challenges and Future Directions 39
8.1 Challenges in translating epigenetic findings 39
There are many difficulties in applying the resear 39
8.2 Personalized medical potential based on histon 39
Despite these challenges, histone modification sti 39
8.3 Future research directions: new biomarkers and 39
9 Concluding Remarks 40

RkJQdWJsaXNoZXIy MjQ4ODYzNA==